Founders Capital Management (Texas)’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$148K Hold
409
0.06% 72
2026
Q1
$144K Hold
409
0.07% 67
2025
Q4
$134K Hold
409
0.07% 71
2025
Q3
$115K Hold
409
0.06% 73
2025
Q2
$114K Hold
409
0.07% 72
2025
Q1
$127K Hold
409
0.08% 63
2024
Q4
$107K Hold
409
0.07% 73
2024
Q3
$132K Hold
409
0.08% 67
2024
Q2
$128K Hold
409
0.08% 68
2024
Q1
$116K Hold
409
0.08% 75
2023
Q4
$118K Hold
409
0.09% 72
2023
Q3
$110K Sell
409
-408
-50% -$102K 0.08% 71
2023
Q2
$181K Hold
817
0.13% 64
2023
Q1
$198K Hold
817
0.15% 57
2022
Q4
$215K Hold
817
0.16% 58
2022
Q3
$184K Hold
817
0.15% 62
2022
Q2
$199K Hold
817
0.16% 59
2022
Q1
$184K Hold
817
0.12% 64
2021
Q4
$184K Hold
817
0.12% 64
2021
Q3
$174K Buy
+817
New +$188K 0.12% 62
2019
Q4
Sell
-11,740
Closed -$2.27M 313
2019
Q3
$2.27M Hold
11,740
1.82% 24
2019
Q2
$2.16M Sell
11,740
-50
-0.4% -$8.95K 1.91% 21
2019
Q1
$2.24M Buy
11,790
+100
+0.9% +$19.1K 2.1% 19
2018
Q4
$2.28M Sell
11,690
-90
-0.8% -$17.6K 2.43% 16
2018
Q3
$2.44M Sell
11,780
-15
-0.1% -$2.96K 2.01% 20
2018
Q2
$2.18M Buy
11,795
+30
+0.3% +$5.31K 1.91% 20
2018
Q1
$2.01M Buy
11,765
+60
+0.5% +$11K 1.69% 25
2017
Q4
$2.04M Sell
11,705
-700
-6% -$124K 1.69% 23
2017
Q3
$2.31M Buy
12,405
+670
+6% +$119K 1.92% 18
2017
Q2
$2.02M Buy
11,735
+4,980
+74% +$810K 1.79% 21
2017
Q1
$1.11M Buy
+6,755
New +$1.12M 1% 34

Other funds holding AMGN

Founders Capital Management (Texas)'s AMGN Position: Q2 2026 in Review

Founders Capital Management (Texas) held its Amgen (AMGN) position steady in Q2 2026 at 409 shares worth $148K. The position accounts for 0.06% of the portfolio, ranked #72.

Founders Capital Management (Texas) first reported a position in AMGN in Q1 2017 and has held it in 31 quarters since. The position peaked at $2.44M in Q3 2018. 1,055 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Founders Capital Management (Texas) held 409 shares of Amgen worth $148K as of Q2 2026.
  • Founders Capital Management (Texas) left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.06% of Founders Capital Management (Texas)'s portfolio in Q2 2026, its #72 holding.
  • Founders Capital Management (Texas) first reported a position in Amgen in Q1 2017 and has held it in 31 quarters since.
  • Founders Capital Management (Texas)'s Amgen position peaked at $2.44M in Q3 2018.
  • 1,055 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q2 2026, filed 21 Jul 2026.